Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biogen Idec Inc Insider Profile
11 Followers
Biogen Idec Inc, Ten Percent Owner at Viracta Therapeutics, holds 2.91M shares in Viracta Therapeutics (Ticker: VIRX), holds 4.42M shares in Tecogen (Ticker: TGEN), holds 17.65M shares in Sangamo Biosciences (Ticker: SGMO). Most recently, Biogen Idec Inc ― shares of Viracta Therapeutics on ― for an estimated value of ―.
Biogen Idec Inc Viracta Therapeutics (VIRX)Ten Percent Owner
Viracta Therapeutics (VIRX)
Ten Percent Owner
Ranked #2,505 out of 98,743 Corporate Insiders
Profitable Transactions
8 out of 8 Profitable Transactions
Average Return
+54.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Biogen Idec Inc holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Aug 31, 2022 - Aug 31, 2023
Return:+82.00%
The most profitable trade made by Biogen Idec Inc
Biogen Idec Inc's Trading History
Viracta Therapeutics
―
Ten Percent Owner
―
$2.39M
Tecogen
―
Ten Percent Owner
―
$3.09M
Sangamo Biosciences
Sep 28, 2023
Ten Percent Owner
Informative Sell
3.00M
$8.86M
List of latest transactions for each holding click on a transaction to see Biogen Idec Inc's performance on stock
You May Also Like
Biogen Idec Inc insider profile FAQ
What is the percentage of profitable transactions made by Biogen Idec Inc?
The percentage of profitable transactions made by Biogen Idec Inc is 100%.
What is the average return per transaction made by Biogen Idec Inc?
The average return per transaction made by Biogen Idec Inc is 54.30%.
What stocks does Biogen Idec Inc hold?
Biogen Idec Inc holds: VIRX, TGEN, SGMO stocks.
What was Biogen Idec Inc’s latest transaction?
Biogen Idec Inc latest transaction was an Uninformative Buy of ―.
What was Biogen Idec Inc's most profitable transaction?
Biogen Idec Inc’s most profitable transaction was an Informative Sell of SGMO stock on August 31, 2022. The return on the trade was 82.00%.
What is Biogen Idec Inc's role in Viracta Therapeutics?
Biogen Idec Inc's role in Viracta Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.